Ernexa Therapeutics ERNA
Ernexa Therapeutics: annual report to shareholders
- Form
- ARS
- Filed
- Importance
- Routine
- Accession
- 0001493152-26-022288
Not explained yet; the original is on EDGAR.
Annual report to shareholders
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Marker Therapeutics MRKR public float $17M, Jun 30, 2025
- Charlie's Holdings CHUC public float $18M, Jun 30, 2025
- Cognition Therapeutics CGTX public float $18M, Jun 30, 2025
- IGC Pharma IGC public float $18M, Jun 30, 2025
- Lipocine LPCN public float $16M, Jun 30, 2025